Lataa...
CD86 regulates myeloma cell survival
Although prognosis for patients with multiple myeloma has improved over the past decade, research toward discovery of new therapeutic avenues is important and could lead to a cure for this plasma cell malignancy. Here we show that blocking the CD28-CD86 pathway via silencing of either CD28 or CD86 l...
Tallennettuna:
| Julkaisussa: | Blood Adv |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729629/ https://ncbi.nlm.nih.gov/pubmed/29296880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011601 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|